Scholar Rock Holding Corp. (SRRK)
42.18
+0.51
(+1.22%)
USD |
NASDAQ |
Jan 09, 16:00
41.66
-0.52
(-1.23%)
After-Hours: 20:00
Scholar Rock Research and Development Expense (Quarterly): 50.06M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Lifeward Ltd. | 0.721M |
| Mersana Therapeutics, Inc. | 12.07M |
| Twist Bioscience Corp. | 17.01M |
| ETHZilla Corp. | -- |
| NovaBay Pharmaceuticals, Inc. | -- |